Prescription Required
Tresiba 100IU/ml Flextouch is a long-acting insulin used to manage diabetes mellitus (Type 1 and Type 2) in adults and children. It contains Insulin Degludec (100IU/ml), which provides stable and prolonged blood sugar control for up to 42 hours. The Flextouch pen allows for easy and precise dosing.
Avoid alcohol as it may cause unpredictable blood sugar changes.
Consult a doctor before use; insulin therapy may need adjustments.
Safe, but monitor blood sugar closely.
Avoid if you experience dizziness or hypoglycemia.
Monitor kidney function, as dose changes may be required.
Use Tresiba 100IU/ml Flextouch with caution in liver disease, as dose adjustments may be needed.
Tresiba 100IU/ml Flextouch is a long-acting insulin that provides consistent, all-day sugar control. It works like your bodys natural insulin. Insulin facilitates reuptake of sugar in muscle and fat cells and also suppresses the production of sugar in the liver. Mimics natural insulin function, helping glucose enter cells for energy production. Provides a steady insulin effect for up to 42 hours, reducing blood sugar fluctuations. Lowers fasting blood sugar levels by enhancing glucose uptake and utilization.
Type 1 Diabetes – A chronic condition where the body produces little or no insulin, requiring lifelong insulin therapy. Type 2 Diabetes – A metabolic disorder where the body becomes resistant to insulin or doesn’t produce enough. Hypoglycemia (Low Blood Sugar) – A condition where blood sugar drops too low, causing dizziness, sweating, and confusion.
Tresiba 100IU/ml Flextouch is a long-acting insulin that provides up to 42 hours of blood sugar control. It offers flexible dosing and reduces nighttime hypoglycemia, making it an ideal choice for diabetes management.
MBA in Pharmaceutical
Content Updated on
Friday, 7 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA